Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | EMBO Rep | 2022 | 35785414 | PubTator, text mining | PubMed |
| Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | Life Sci Alliance | 2022 | 35777956 | PubTator, text mining | PubMed |
| C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | Proc Natl Acad Sci U S A | 2022 | 35776542 | PubTator, text mining | PubMed |
| Lamin B2 contributes to the proliferation of bladder cancer cells via activating the expression of cell division cycle‑associated protein 3. | Int J Mol Med | 2022 | 35775376 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications. | Front Genet | 2022 | 35774512 | PubTator, text mining | PubMed |
| Species determination using AI machine-learning algorithms: Hebeloma as a case study. | IMA Fungus | 2022 | 35773719 | PubTator, text mining | PubMed |
| Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival. | BMC Cancer | 2022 | 35761298 | PubTator, text mining | PubMed |
| Inhibition of N-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication. | Int J Mol Sci | 2022 | 35743017 | PubTator, text mining | PubMed |
| DDK: The Outsourced Kinase of Chromosome Maintenance. | Biology (Basel) | 2022 | 35741398 | PubTator, text mining | PubMed |
| IGF1R and LOX Modules Are Related to Antler Growth Rate Revealed by Integrated Analyses of Genomics and Transcriptomics. | Animals (Basel) | 2022 | 35739859 | PubTator, text mining | PubMed |
| Selective role of the DNA helicase Mcm5 in BMP retrograde signaling during Drosophila neuronal differentiation. | PLoS Genet | 2022 | 35737938 | PubTator, text mining | PubMed |
| WASHC1 interacts with MCM2-7 complex to promote cell survival under replication stress. | Mol Biol Rep | 2022 | 35733063 | PubTator, text mining | PubMed |
| MCM6 Promotes Hepatocellular Carcinoma Progression via the Notch Pathway: Clinical, Functional, and Genomic Insights. | Comput Math Methods Med | 2022 | 35720029 | PubTator, text mining | PubMed |
| FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta-Analysis and Bioinformatics Analysis. | Front Oncol | 2022 | 35719909 | PubTator, text mining | PubMed |
| 3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo. | J Cancer | 2022 | 35711839 | PubTator, text mining | PubMed |
| The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms. | J Exp Clin Cancer Res | 2022 | 35701841 | PubTator, text mining | PubMed |
| A novel epithelial-mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma. | Hepatol Int | 2022 | 35699863 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of the Expression and Clinical Significance of the DNA Replication Regulator MCM Complex in Bladder Cancer. | Int J Gen Med | 2022 | 35698656 | PubTator, text mining | PubMed |
| Gene expression profiling and protein-protein interaction analysis reveals the dynamic role of MCM7 in Alzheimer's disorder and breast cancer. | 3 Biotech | 2022 | 35698583 | PubTator, text mining | PubMed |
| Role of CD47 in tumor immunity: a potential target for combination therapy. | Sci Rep | 2022 | 35697717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=22